FBLN2
protein-codingfibulin 2, the group of Fibulins
Gene summary
This gene encodes an extracellular matrix protein, which belongs to the fibulin family. This protein binds various extracellular ligands and calcium. It may play a role during organ development, in particular, during the differentiation of heart, skeletal and neuronal structures. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~89.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0005453
Submitter: ClinGen
*FBLN2* was first reported in relation to autosomal dominant congenital heart disease in 2012 (Ackerman et al., PMID:23040494). One proband with a truncating variant reported in a publication was included in this curation (PMID: 33084842). This gene-disease relationship is supported by expression studies and biochemical function study (PMIDs: 7851641, 11507771, 21743496). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Congenital Heart Disease GCEP on the meeting date 11/27/2023 (SOP Version 10)
Inheritance Pattern: AD
Disease ID:MONDO:0015924
Submitter: ClinGen
FBLN2 was first reported in relation to autosomal dominant pulmonary arterial hypertension (PAH) in 2021 (Zhu et al., PMID: 33971972) in a case control study. Out of a cohort of 1647 idiopathic PAH cases, 3 rare predicted deleterious missense variants were identified in 6 unrelated individuals with one variant recurrent in four individuals. The relationship between FBLN2 and PAH is also supported by expression evidence from GTEx bulk tissue expression. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen PH Gene Curation Expert Panel on 8/30/2022 (SOP Version 9).
Inheritance Pattern: AD
Disease ID:MONDO:0015924
Submitter: PanelApp Australia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FBLN2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001004019.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 3 | 3 | 8 | ||
| missense | 236 | 6 | 2 | 244 | ||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 0 | 0 | 242 | 9 | 5 | 256 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001004019.1 | 17 | MANE Select | |
| Ensembl | ENSP00000384169.3 | 17 | MANE Select | |
| RefSeq | NP_001158507.1 | 17 | Standard | |
| RefSeq | NP_001989.2 | 16 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Extracellular matrix organization
- Molecules associated with elastic fibres
- Elastic fibre formation
Biological Process
- positive regulation of cell-substrate adhesion
- extracellular matrix organization
Molecular Function
- extracellular matrix structural constituent
- calcium ion binding
- extracellular matrix constituent conferring elasticity
- extracellular matrix binding
Cellular Component
- extracellular region
- extracellular matrix
- collagen-containing extracellular matrix
- extracellular vesicle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000404922
- Coding exons
- 17
- Length
- 106099
- Individuals with no LoFs
- 124641
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 37
- Defined
- 124678
- p
- 0.000148
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.766 | 705 | 765 | 0.922 | 0.0000504 | 7887 |
| Missense (PolyPhen) | 257 | 336.92 | 0.7628 | 3615 | ||
| Synonymous | 0.624 | 320 | 335 | 0.957 | 0.0000248 | 2450 |
| Loss of Function | 4.38 | 19 | 53.6 | 0.354 | 0.00000282 | 591 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00026 | 0.00026 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00012 | 0.00011 | rare |
| Finnish | 0.00024 | 0.00023 | rare |
| European (Non-Finnish) | 0.00015 | 0.00015 | rare |
| South Asian | 0.00010 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Its binding to fibronectin and some other ligands is calcium dependent. May act as an adapter that mediates the interaction between FBN1 and ELN (PubMed:17255108). {ECO:0000269|PubMed:17255108}.;
Recessive Scores
- pRec
- 0.225
Intolerance Scores
- LoFtool
- 0.0720
- RVIS EVS
- -1.09
- RVIS percentile EVS
- 6.99
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.586
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |